Home
Drugs
Measles vaccine

Measles vaccine

Drug

Related News

Bangladesh Launches Emergency Measles Vaccination Campaign Amid Deadly Outbreak

Apr 07, 2026

Bangladesh has launched an emergency measles vaccination campaign targeting over one million children as a deadly outbreak spreads across 56 districts. The outbreak has caused at least 17 confirmed deaths with 113 suspected fatalities and over 7,500 infections. The campaign prioritizes children aged six months to five years in high-risk areas amid concerns about critical immunity gaps and overwhelmed healthcare facilities.

Measles Cases Rise in U.S. as Health Systems Face Preparedness Challenge

Mar 18, 2026

Measles cases are reappearing across the United States, challenging health systems unprepared for a disease declared eliminated in 2000. Clinical leaders must ensure rapid identification, isolation protocols, and vaccination strategies to prevent outbreaks.

Measles Cases Surge in U.S. and UK Amid Declining Vaccination Rates

Feb 25, 2026

The U.S. recorded 2,280 measles cases in 2025, the highest since 1991, with 982 cases already confirmed in early 2026. North London faces an outbreak with 34 children infected in Enfield, while Philadelphia issued an exposure alert for the international airport.

Measles Outbreaks Spread Across U.S. as Officials Urge Vaccination

Feb 11, 2026

Measles cases are rising across multiple states, with over 40 cases at a Florida college and 18 cases in North Carolina since December. Federal health officials are urging vaccination as the U.S. recorded 2,280 cases in 2025.

Related Clinical Trials

NCT ID	Title	Status	Phase
NCT05794230	Study of a Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Given With Routine Pediatric Vaccines in Healthy Infants and Toddlers in India and the Republic of South Africa	COMPLETED	PHASE3
NCT04899765	Measles and BCG Vaccines for Mother and Child	RECRUITING	PHASE4
NCT04220671	Measles Vaccination at Health System Contacts	ENROLLING_BY_INVITATION	PHASE4
NCT03460002	Vaccine Campaign Effects on General Hospital Admissions and Mortality Among Children	COMPLETED	PHASE4
NCT03330171	Safety and Immunogenicity of Measles Vaccine, Varicella Vaccine and Hepatitis-A Vaccine	UNKNOWN	PHASE4
NCT03170765	Randomized Controlled Trial of Measles Vaccination Schedule	UNKNOWN	NA
NCT02943681	A Second Dose of Measles Vaccine (MV) in the Second Year of Life	COMPLETED	NA
NCT02058927	Immune Reconstitution to Measles Virus of HIV Infected Children in Zambia	COMPLETED
NCT01486355	Additional Measles Vaccine at 4 Months of Age	UNKNOWN	PHASE4
NCT01345240	Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049)	COMPLETED	PHASE3